Stem Cell Ophthalmology Treatment Study (SCOTS): improvement in serpiginous choroidopathy following autologous bone marrow derived stem cell treatment

Stem Cell Ophthalmology Treatment Study (SCOTS): improvement in serpiginous choroidopathy following autologous bone marrow derived stem cell treatment

We report results in a 77-year-old male patient with visual loss from long-standing serpiginous choroidopathy treated with bone marrow derived stem cells (BMSC) within the Stem Cell Ophthalmology Treatment Study (SCOTS). SCOTS is an Institutional Review Board approved clinical trial and the largest...

Full description

Bibliographic Details
Main Authors: Jeffrey N Weiss, Susan C Benes, Steven Levy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Neural Regeneration Research
Subjects:
serpiginous choroidopathy; serpigionous choroiditis; geographic helicoid peripapillary chroidopathy; retina; macula; stem cell therapy; uveitis
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=9;spage=1512;epage=1516;aulast=Weiss

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=9;spage=1512;epage=1516;aulast=Weiss

Similar Items